These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6677967)

  • 1. [Old and new cephalosporins: comparative study of their activity in vitro against bacteria isolated from infectious processes].
    Prado V; Reyes L; Braun S; Bosch P
    Rev Med Chil; 1983 Dec; 111(12):1241-7. PubMed ID: 6677967
    [No Abstract]   [Full Text] [Related]  

  • 2. Compared sensitivities of 532 bacterial strains to six cephalosporins.
    Courtieu AL; Drugeon H
    Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the microbial sensitivity to antibiotics with special reference to cephalosporins of microorganisms isolated from patients with respiratory tract infections].
    Cipolloni AP; Cenciotti L
    G Clin Med; 1977; 58(7-8):278-89. PubMed ID: 924050
    [No Abstract]   [Full Text] [Related]  

  • 4. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The microbiologic activity of cephalothin, cephalexin, cephacetrile, cephradine, cephazolin and cephamandol].
    Knothe H; Lauer B
    Adv Clin Pharmacol; 1974; 8():80-8. PubMed ID: 4468733
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
    Digranes A; Bjorvatn B
    NIPH Ann; 1980 Dec; 3(2):141-7. PubMed ID: 7219840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of six frequently isolated bacteria in intensive care unit patients to some cephalosporins and aminoglycosides.
    Carrington da Costa RB; Costa D; Pimentel J; Conçalves J; Rebelo A; Costa JJ
    J Chemother; 1989 Jul; 1(4 Suppl):323. PubMed ID: 16312421
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial activity of cefquinome against equine bacterial pathogens.
    Thomas E; Thomas V; Wilhelm C
    Vet Microbiol; 2006 Jun; 115(1-3):140-7. PubMed ID: 16455213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cephalosporins--microbiological bases for their utilization in therapy (author's transl)].
    Výmola F; Jedlicková Z
    Cas Lek Cesk; 1976 May; 115(20-21):606-8. PubMed ID: 1277244
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cephalosporin sensitivity of microbial strains isolated from pregnant women and newborn infants].
    Shopova E
    Akush Ginekol (Sofiia); 1995; 34(2):62-3. PubMed ID: 8651432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies of the antibacterial effect of so-called basic cephalosporins].
    Ruckdeschel G
    Med Klin (Munich); 1988 Dec; 83(24):825-31. PubMed ID: 3062348
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefepime: part of the new generation.
    Rybak MJ; Palmer SM
    Am J Hosp Pharm; 1994 Feb; 51(4):459-60. PubMed ID: 8017410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cephalosporins].
    Friis H
    Ugeskr Laeger; 1984 Aug; 146(32):2419-24. PubMed ID: 6515847
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
    Gatti M; Varoli O; Piscolla F
    J Chemother; 1989 Jul; 1(4 Suppl):103-4. PubMed ID: 16312324
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro evaluation of Ly 163892, a new oral cephalosporin.
    Schäfer V; Knothe H; Sammann A; Heidron F
    J Chemother; 1989 Jul; 1(4 Suppl):123-4. PubMed ID: 16312333
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of BMY-28100 against common isolates from pediatric infections.
    Scribner RK; Marks MI; Finkhouse BD
    Antimicrob Agents Chemother; 1987 Apr; 31(4):630-1. PubMed ID: 3606067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.